← Back to Search

Behavioural Intervention

Home-based multicomponent exercise intervention program for Aphasia (HEPPA Trial)

N/A

Waitlist Available

Led By Louis Bherer

Research Sponsored by Montreal Heart Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

A clinical diagnosis of Primary Progressive Aphasia

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months post-intervention

Awards & highlights

HEPPA Trial Summary

This trial is testing a new exercise program that can be done at home by adults with Primary Progressive Aphasia. The goal is to see if the program is practical and effective.

Who is the study for?

This trial is for adults with Primary Progressive Aphasia, a type of language disorder. Participants should be clinically diagnosed and able to perform basic exercises at home.Check my eligibility

What is being tested?

The study tests a new exercise program done at home designed for people with language disorders like Primary Progressive Aphasia. It's a pilot study, meaning it's an early test to see if the idea is feasible.See study design

What are the potential side effects?

Since this is an exercise-based intervention, potential side effects may include muscle soreness, fatigue, or injury from physical activity. Specific risks will depend on individual health conditions.

HEPPA Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with Primary Progressive Aphasia.

HEPPA Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months post-intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months post-intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Evaluate the compliance rate of a 6-month exercise intervention in individuals with Primary Progressive Aphasia

Evaluate the program completion rate of a 6-month exercise intervention in individuals with Primary Progressive Aphasia

Evaluate the recruitment rate of a 6-month exercise intervention in individuals with Primary Progressive Aphasia

+2 more

Secondary outcome measures

Document change in balance performance

Document change in lower limb muscle strength

Document change in upper limb muscle strength

+17 more

Other outcome measures

Document Cognitive Reserve

Document changes in anxiety

Document changes in depressive symptomatology

+7 more

HEPPA Trial Design

1Treatment groups

Experimental Treatment

Group I: Home-based multicomponent exercise intervention programExperimental Treatment1 Intervention

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Montreal Heart InstituteLead Sponsor

120 Previous Clinical Trials

68,806 Total Patients Enrolled

Louis BhererPrincipal InvestigatorCentre ÉPIC, Institut de cardiologie de Montréal

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are patients currently eligible to participate in this ongoing medical study?

"As per the information available on clinicaltrials.gov, this particular study is not currently in the recruitment phase. It was initially posted on April 5th, 2023, and last updated on December 12th, 2023. However, it's worth noting that there are currently 175 other ongoing clinical trials actively seeking participants at this time."

Answered by AI

Recent research and studies

NeurologyJournal

Classification of Primary Progressive Aphasia and Its Variants

Gorno-Tempini, M. L., A. E. Hillis, S. Weintraub, A. Kertesz, M. Mendez, S. F. Cappa, J. M. Ogar, et al.. 2011. “Classification of Primary Progressive Aphasia and Its Variants”. Neurology. Ovid Technologies (Wolters Kluwer Health). doi:10.1212/wnl.0b013e31821103e6.

NeurologyJournal

Clinical Syndromes Associated with Posterior Atrophy: Early Age at Onset AD Spectrum

Migliaccio, R., F. Agosta, K. Rascovsky, A. Karydas, S. Bonasera, G. D. Rabinovici, B. L. Miller, and M. L. Gorno-Tempini. 2009. “Clinical Syndromes Associated with Posterior Atrophy: Early Age at Onset AD Spectrum”. Neurology. Ovid Technologies (Wolters Kluwer Health). doi:10.1212/wnl.0b013e3181c0d427.

CortexJournal

Phonological Short-term Memory in Logopenic Variant Primary Progressive Aphasia and Mild Alzheimer's Disease

Meyer, Aaron M., Sarah F. Snider, Rachael E. Campbell, and Rhonda B. Friedman. 2015. “Phonological Short-term Memory in Logopenic Variant Primary Progressive Aphasia and Mild Alzheimer's Disease”. Cortex. Elsevier BV. doi:10.1016/j.cortex.2015.07.003.

clinicaltrials.govStudy